Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hospitalization and mortality in patients with COVID-19 with or at risk of type 2 diabetes: data from five health systems in Pennsylvania and Maryland
Hsin‐Chieh Yeh, Jennifer L. Kraschnewski, Lan Kong, et al.
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 3, pp. e002774-e002774
Open Access | Times Cited: 10

Showing 10 citing articles:

SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-Analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 67-67
Open Access
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 12
Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19
Zheng Zhu, Qingya Zeng, Qinyu Liu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2244652-e2244652
Open Access | Times Cited: 21
Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
Diabetes Research and Clinical Practice (2022) Vol. 195, pp. 110205-110205
Open Access | Times Cited: 20
Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
Carmen Tisch, Eleni Xourgia, Aristomenis K. Exadaktylos, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 660-675
Open Access | Times Cited: 2
Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study
Н. Г. Мокрышева, М. В. Шестакова, Olga Konstantinovna Vikulova, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 5, pp. 404-417
Open Access | Times Cited: 13
Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection
Patricia-Andrada Reștea, Mariana Mureşan, Adrian Voicu, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 392-392
Open Access | Times Cited: 2
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
Bariatric surgery and COVID-19 outcomes: results from the PaTH to Health: Diabetes study
Taraneh Soleymani, Erik Lehman, Lan Kong, et al.
Surgery for Obesity and Related Diseases (2024) Vol. 20, Iss. 11, pp. 1039-1045
Closed Access
Health Care Disparities in Outpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic: Where Do We Stand Now?
Eric D. Frontera, Melissa K. Cavagahan, Allie Carter, et al.
Endocrine Practice (2023) Vol. 29, Iss. 7, pp. 529-537
Open Access
Page 1

Scroll to top